National campaign kicks off in Pune to raise awareness on HPV-linked cancers, promote vaccination, and empower communities through expert-led public health education....
Next-Generation INTERCEPT Blood Safety Device Receives Multiple International Regulatory Clearances for Broader Adoption....
Amid a former President’s diagnosis, breakthrough technology offers earlier, more accurate detection—raising urgent questions about systemic delays in adoption ...
Milestone highlights growing clinical adoption of AI-powered, non-invasive technology for early melanoma diagnosis. ...
European regulatory approval paves the way for Dermalyser’s clinical rollout, enhancing early skin cancer diagnosis through advanced AI technology....
Groundbreaking non-active implant for acid reflux draws global attention and fuels U.S. clinical engagement at world’s premier GI conference....
Chinese MedTech Leader Highlights Inclusive Solutions and Global Collaboration at World Health Assembly Side Event...
AI-Powered Risk Prediction Tool Enhances Early Detection of Cardiac Arrest, Advancing Critical Care Monitoring. ...
Meril’s groundbreaking trial demonstrates the efficacy and safety of the MGuard™ device, marking a major milestone in cardiovascular treatment and paving the way for improved patient outcomes worldwide...
New bioengineered device aims to transform treatment of peripheral nerve injuries with first-in-human evaluation now underway....
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
